VRTX: Vertex Pharmaceuticals Incorporated Stocks News on November 4, 2025

VRTX

MT Newswires

4 hours ago

Bernstein Adjusts Price Target on Vertex Pharmaceuticals to $466 From $471, Maintains Market Perform Rating

VRTX

MT Newswires

4 hours ago

Barclays Adjusts Price Target on Vertex Pharmaceuticals to $414 From $408, Maintains Equalweight Rating

VRTX

MT Newswires

4 hours ago

Stifel Adjusts Price Target on Vertex Pharmaceuticals to $445 From $455, Maintains Hold Rating

VRTX

MT Newswires

4 hours ago

Goldman Sachs Adjusts Price Target on Vertex Pharmaceuticals to $604 From $603, Maintains Buy Rating

Vortex Energy Corp. Announces Submission of Abstract for Presentation at the 2026 Canadian Hydrogen Convention

VRTX

GlobeNewswire

5 hours ago

Vortex Energy Corp. Announces Submission of Abstract for Presentation at the 2026 Canadian Hydrogen Convention

VRTX

MT Newswires

5 hours ago

RBC Lowers Price Target on Vertex Pharmaceuticals to $415 From $423, Keeps Sector Perform Rating

Vertex Pharma's Mixed Quarter: How Legacy Products Drove Its Beat

VRTX

Investor's Business Daily

19 hours ago

Vertex Pharma's Mixed Quarter: How Legacy Products Drove Its Beat

VRTX

Zacks

20 hours ago

Vertex (VRTX) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates

2 Healthcare Stocks for Individual Investors With a 20-Year Time Horizon

VRTX

Motley Fool

a day ago

2 Healthcare Stocks for Individual Investors With a 20-Year Time Horizon

McDonald’s Earnings, Tariff Update, Musk Pay Vote: What to Watch This Week

VRTX

The Wall Street Journal

a day ago

McDonald’s Earnings, Tariff Update, Musk Pay Vote: What to Watch This Week

VRTX

Simply Wall St.

2 days ago

Vertex Pharmaceuticals (VRTX): Exploring Valuation After Promising Kidney Therapy Results and Growth in New Treatments

VRTX

Motley Fool

2 days ago

My Top Growth Stock to Buy in November

Palantir, AMD, Pfizer, Robinhood, McDonald’s, and Many More Stocks to Watch This Week

VRTX

Barrons.com

2 days ago

Palantir, AMD, Pfizer, Robinhood, McDonald’s, and Many More Stocks to Watch This Week

Fed fallout, missing jobs numbers, and a busy earnings calendar: What to watch this week

VRTX

Yahoo Finance

2 days ago

Fed fallout, missing jobs numbers, and a busy earnings calendar: What to watch this week

VRTX

StockStory

3 days ago

Vertex Pharmaceuticals (VRTX) Q3 Earnings: What To Expect

SNAP benefits expire, open enrollment, earnings: What to Watch

VRTX

Yahoo Finance Video

4 days ago

SNAP benefits expire, open enrollment, earnings: What to Watch

Rigel Gears Up to Report Q3 Earnings: Here's What to Expect

VRTX

Zacks

4 days ago

Rigel Gears Up to Report Q3 Earnings: Here's What to Expect

Vertex Pharma’s Stock Has Tumbled. Earnings Will Stop the Pain.

VRTX

Barrons.com

5 days ago

Vertex Pharma’s Stock Has Tumbled. Earnings Will Stop the Pain.

VRTX

Zacks

6 days ago

Vertex Pharmaceuticals (VRTX) Stock Moves -1.23%: What You Should Know

Amgen's Q3 Earnings in the Cards: Here's What to Expect

VRTX

Zacks

6 days ago

Amgen's Q3 Earnings in the Cards: Here's What to Expect

VRTX

Zacks

6 days ago

Exploring Analyst Estimates for Vertex (VRTX) Q3 Earnings, Beyond Revenue and EPS

VRTX

Insider Monkey

7 days ago

H.C. Wainwright Reiterates a Buy Rating on Vertex Pharmaceuticals (VRTX)

Vertex Pharmaceuticals Stock Rises 8.9% as Pipeline Progress Renews Valuation Debate

VRTX

Simply Wall St.

7 days ago

Vertex Pharmaceuticals Stock Rises 8.9% as Pipeline Progress Renews Valuation Debate

Vertex Gears Up to Report Q3 Earnings: Is a Beat in the Cards?

VRTX

Zacks

7 days ago

Vertex Gears Up to Report Q3 Earnings: Is a Beat in the Cards?

Will Ultragenyx (RARE) Report Negative Q3 Earnings? What You Should Know

VRTX

Zacks

7 days ago

Will Ultragenyx (RARE) Report Negative Q3 Earnings? What You Should Know

If I Could Only Buy 2 Stocks in the Last Quarter of 2025, I'd Pick These

VRTX

Motley Fool

7 days ago

If I Could Only Buy 2 Stocks in the Last Quarter of 2025, I'd Pick These

Vertex to Participate in the UBS Global Healthcare Conference on November 11

VRTX

Business Wire

8 days ago

Vertex to Participate in the UBS Global Healthcare Conference on November 11

Intellia Therapeutics Stock Drops as Safety Fears Emerge in Drug Trial

VRTX

Barrons.com

8 days ago

Intellia Therapeutics Stock Drops as Safety Fears Emerge in Drug Trial

VRTX

Zacks

8 days ago

Vertex Pharmaceuticals (VRTX) Earnings Expected to Grow: Should You Buy?

How to Find Strong Medical Stocks Slated for Positive Earnings Surprises

VRTX

Zacks

8 days ago

How to Find Strong Medical Stocks Slated for Positive Earnings Surprises

Prediction: Vertex Pharmaceuticals Will Be Worth More Than Pfizer by 2030

VRTX

Motley Fool

8 days ago

Prediction: Vertex Pharmaceuticals Will Be Worth More Than Pfizer by 2030

VRTX

Simply Wall St.

12 days ago

Did FDA Progress on Povetacicept and New Data for ALYFTREK Just Shift Vertex’s (VRTX) Investment Narrative?

Vertex Presents New Data Across Portfolio of Cystic Fibrosis Medicines Including ALYFTREK® at the North American Cystic Fibrosis Conference

VRTX

Business Wire

12 days ago

Vertex Presents New Data Across Portfolio of Cystic Fibrosis Medicines Including ALYFTREK® at the North American Cystic Fibrosis Conference

VRTX

Insider Monkey

13 days ago

Bank of America Securities Remains Bullish on Vertex Pharmaceuticals Incorporated (VRTX)

VRTX

Zacks

13 days ago

Vertex Pharmaceuticals Incorporated (VRTX) Is a Trending Stock: Facts to Know Before Betting on It

2 Growth Stocks to Invest $1,000 in Right Now

VRTX

Motley Fool

16 days ago

2 Growth Stocks to Invest $1,000 in Right Now

VRTX

Simply Wall St.

17 days ago

A Closer Look at Vertex Pharmaceuticals (VRTX) Valuation After Recent Share Price Stability

VRTX

Zacks

18 days ago

Vertex Pharmaceuticals (VRTX) Outpaces Stock Market Gains: What You Should Know

VRTX

MT Newswires

18 days ago

Goldman Sachs Cuts Vertex Pharmaceuticals Price Target to $603 From $624, Buy Rating Kept

VRTX

MT Newswires

18 days ago

Vertex Pharma Says FDA Grants Rolling Review of Povetacicept Application for IgA Nephropathy

Vertex Announces Progress in Povetacicept Development Program and Presentation of New Data at American Society of Nephrology Kidney Week

VRTX

Business Wire

18 days ago

Vertex Announces Progress in Povetacicept Development Program and Presentation of New Data at American Society of Nephrology Kidney Week

Vertex Pharmaceuticals: Commercial Pipeline Is Stronger Than What The Market Thinks

VRTX

GuruFocus.com

18 days ago

Vertex Pharmaceuticals: Commercial Pipeline Is Stronger Than What The Market Thinks

Earnings Preview: What To Expect From Vertex Pharmaceuticals' Report

VRTX

Barchart

19 days ago

Earnings Preview: What To Expect From Vertex Pharmaceuticals' Report

VRTX

Zacks

20 days ago

Vertex Pharmaceuticals (VRTX) Stock Sinks As Market Gains: What You Should Know

Adtalem, Google Cloud to launch AI credential program for healthcare professionals

VRTX

Reuters

20 days ago

Adtalem, Google Cloud to launch AI credential program for healthcare professionals

2 Unstoppable Growth Stocks to Buy During a Market Crash

VRTX

Motley Fool

20 days ago

2 Unstoppable Growth Stocks to Buy During a Market Crash

VRTX

Zacks

a month ago

Here's Why Vertex Pharmaceuticals (VRTX) Fell More Than Broader Market

Is Vertex Stock Poised for Growth After Positive CRISPR Therapy Trial Results in 2025?

VRTX

Simply Wall St.

a month ago

Is Vertex Stock Poised for Growth After Positive CRISPR Therapy Trial Results in 2025?

How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings

VRTX

Zacks

a month ago

How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings

Odyssey Therapeutics Appoints Pharmaceutical Leader Nia Tatsis, Ph.D., to Its Board of Directors

VRTX

Business Wire

a month ago

Odyssey Therapeutics Appoints Pharmaceutical Leader Nia Tatsis, Ph.D., to Its Board of Directors

CRISPR Therapeutics (CRSP) Surges 8.7%: Is This an Indication of Further Gains?

VRTX

Zacks

a month ago

CRISPR Therapeutics (CRSP) Surges 8.7%: Is This an Indication of Further Gains?

VRTX

Morningstar Research

a month ago

Analyst Report: Vertex Pharmaceuticals Incorporated

VRTX

Zacks

a month ago

Investors Heavily Search Vertex Pharmaceuticals Incorporated (VRTX): Here is What You Need to Know

VRTX

MT Newswires

a month ago

JPMorgan Adjusts PT on Vertex Pharmaceuticals to $530 From $517, Maintains Overweight Rating

VRTX

MT Newswires

a month ago

RBC Raises Price Target on Vertex Pharmaceuticals to $423 From $405, Keeps Sector Perform Rating

The Smartest Growth Stock to Buy With $500 Right Now

VRTX

Motley Fool

a month ago

The Smartest Growth Stock to Buy With $500 Right Now

VRTX

StockStory

a month ago

Vertex Pharmaceuticals (VRTX): Buy, Sell, or Hold Post Q2 Earnings?

Vertex to Announce Third Quarter 2025 Financial Results on November 3rd

VRTX

Business Wire

a month ago

Vertex to Announce Third Quarter 2025 Financial Results on November 3rd

VRTX

Insider Monkey

a month ago

What Makes Vertex Pharmaceuticals (VRTX) an Investment Bet?

These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar

VRTX

Zacks

a month ago

These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar

1 Healthcare Stock with Exciting Potential and 2 Facing Challenges

VRTX

StockStory

a month ago

1 Healthcare Stock with Exciting Potential and 2 Facing Challenges

2 Beaten-Down Stocks Primed for a Comeback

VRTX

Motley Fool

a month ago

2 Beaten-Down Stocks Primed for a Comeback

VRTX

Zacks

a month ago

Vertex Pharmaceuticals (VRTX) Stock Dips While Market Gains: Key Facts

VRTX

Simply Wall St.

a month ago

Vertex Pharmaceuticals (VRTX): Assessing Valuation as Shares Hold Steady and Long-Term Prospects Remain Key

3 Growth Stocks That Could Be 10-Baggers in 10 Years

VRTX

Motley Fool

a month ago

3 Growth Stocks That Could Be 10-Baggers in 10 Years

VRTX

Zacks

a month ago

Vertex Pharmaceuticals (VRTX) Exceeds Market Returns: Some Facts to Consider

VRTX

Insider Monkey

a month ago

Vertex Pharmaceuticals (VRTX) Highlights Pipeline Progress at BofA Global Healthcare Conference

VRTX

MT Newswires

a month ago

Citigroup Adjusts Price Target on Vertex Pharmaceuticals to $575 From $550, Maintains Buy Rating

Will the first fibromyalgia drug in 15 years deliver a breakthrough in pain?

VRTX

Pharma Voice

a month ago

Will the first fibromyalgia drug in 15 years deliver a breakthrough in pain?

2 S&P 500 Stocks to Research Further and 1 We Avoid

VRTX

StockStory

a month ago

2 S&P 500 Stocks to Research Further and 1 We Avoid

VRTX

Simply Wall St.

a month ago

What Vertex Pharmaceuticals (VRTX)'s FDA Breakthrough for Povetacicept Means for Kidney Disease Pipeline

VRTX

Zacks

a month ago

Vertex Pharmaceuticals (VRTX) Surpasses Market Returns: Some Facts Worth Knowing

VRTX

Zacks

a month ago

Vertex (VRTX) Is Considered a Good Investment by Brokers: Is That True?

VRTX

Zacks

a month ago

Vertex Pharmaceuticals (VRTX) Ascends While Market Falls: Some Facts to Note

VRTX

Zacks

a month ago

Vertex Pharmaceuticals Incorporated (VRTX) is Attracting Investor Attention: Here is What You Should Know

VRTX

MT Newswires

a month ago

Vertex Says FDA Granted Breakthrough Therapy Status for Immunoglobulin A Nephropathy Treatment

Vertex Announces Key Advancements Across Kidney Portfolio

VRTX

Business Wire

a month ago

Vertex Announces Key Advancements Across Kidney Portfolio

VRTX

MT Newswires

a month ago

Leerink Partners Upgrades Vertex Pharmaceuticals to Outperform From Market Perform, Adjusts PT to $456 From $458

VRTX

Motley Fool

a month ago

My 3 Favorite Stocks to Buy Right Now

CRSP & Sirius Begin Dosing in Thromboembolic Disorder Study in EU

VRTX

Zacks

a month ago

CRSP & Sirius Begin Dosing in Thromboembolic Disorder Study in EU

Vertex Partners with Basketball World Champion Jayson Tatum to Raise Awareness of JOURNAVX®, a Non-Opioid Medicine Approved for the Treatment of Moderate-to-Severe-Acute Pain

VRTX

Business Wire

a month ago

Vertex Partners with Basketball World Champion Jayson Tatum to Raise Awareness of JOURNAVX®, a Non-Opioid Medicine Approved for the Treatment of Moderate-to-Severe-Acute Pain

VRTX

StockStory

a month ago

Unpacking Q2 Earnings: Vertex Pharmaceuticals (NASDAQ:VRTX) In The Context Of Other Therapeutics Stocks

Healthcare Stocks Are at an Historic Low and a Turnaround Is on the Horizon

VRTX

Motley Fool

a month ago

Healthcare Stocks Are at an Historic Low and a Turnaround Is on the Horizon

Arvinas reboots, cuts more staff; Porges joins Lazard

VRTX

BioPharma Dive

2 months ago

Arvinas reboots, cuts more staff; Porges joins Lazard

VRTX

MT Newswires

2 months ago

Vertex Pharmaceuticals Signs Reimbursement Deal With Italy for Casgevy Therapy

Vertex Announces CASGEVY® Reimbursement Agreement for the Treatment of Transfusion-Dependent Beta Thalassemia and Sickle Cell Disease in Italy

VRTX

Business Wire

2 months ago

Vertex Announces CASGEVY® Reimbursement Agreement for the Treatment of Transfusion-Dependent Beta Thalassemia and Sickle Cell Disease in Italy

VRTX

Zacks

2 months ago

Vertex Pharmaceuticals (VRTX) Declines More Than Market: Some Information for Investors

Wall Street Giant Just Gave Itself a $25/Hour Floor--Here's What That Means

VRTX

GuruFocus.com

2 months ago

Wall Street Giant Just Gave Itself a $25/Hour Floor--Here's What That Means

VRTX

Associated Press Finance

2 months ago

BC-Merc Table

VRTX

Associated Press Finance

2 months ago

BC-Sugar Futures

VRTX

Associated Press Finance

2 months ago

BC-BOT-Table

VRTX

Associated Press Finance

2 months ago

BC-US-Foreign Exchange

VRTX

Associated Press Finance

2 months ago

BC-Gold Futures

VRTX

Associated Press Finance

2 months ago

BC-Corn Futures

VRTX

Associated Press Finance

2 months ago

BC-Wheat Futures

VRTX

Motley Fool

2 months ago

2 Growth Stocks to Buy and Hold Forever

Vertex Plunges Around 24% in Six Months: How to Play the Stock

VRTX

Zacks

2 months ago

Vertex Plunges Around 24% in Six Months: How to Play the Stock

How Recent FDA Approval Impacts the Valuation Story for Vertex Pharmaceuticals in 2025

VRTX

Simply Wall St.

2 months ago

How Recent FDA Approval Impacts the Valuation Story for Vertex Pharmaceuticals in 2025

Alger Russell Innovation Index Updates for Third Quarter 2025

VRTX

PR Newswire

2 months ago

Alger Russell Innovation Index Updates for Third Quarter 2025

1 Reason Wall Street Is Obsessed With Vertex Pharmaceuticals

VRTX

Motley Fool

2 months ago

Latest Vertex Pharmaceuticals Incorporated (VRTX) News on November 4, 2025

Share on Social Networks: